权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Natural killer cell and T-cell crosstalk in CMV infection

CMV 感染中的自然杀伤细胞和 T 细胞串扰

基本信息

批准号：
9398188
负责人：
KATHARINE C HSU
金额：
$ 30.63万
依托单位：
SLOAN-KETTERING INST CAN RESEARCH
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-02-15 至 2019-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9398188
关键词：
Activated Natural Killer Cell Adoptive Transfer Affect Alpha Cell Antigen-Presenting Cells Antigens Autologous Binding Biological Assay Blood specimen C57BL/6 Mouse CD8-Positive T-Lymphocytes Cell Communication Cell Transplants Cell physiology Cell surface Cells Chronic Cytomegalovirus Cytomegalovirus Infections Cytotoxic T-Lymphocytes Data Dendritic Cells Development Equilibrium Goals Hematopoietic Human Immune Immune response Immune system Immunocompromised Host In Vitro Incubated Individual Infection Innate Immune System Kinetics Knowledge Lymphocyte Maintenance Mediating Memory Modeling Morbidity - disease rate Mus Natural Immunity Natural Killer Cells Newborn Infant Organ PDCD1LG1 gene Patients Peptides Phenotype Physiologic pulse Population Recovery Shapes Solid Stem cell transplant Surface System T cell response T-Cell Proliferation T-Lymphocyte Transplant Recipients Transplantation Up-Regulation Viral Virus Virus Diseases cohort comparative hematopoietic cell transplantation in vivo inhibiting antibody insight mortality mouse model novel pathogen peripheral blood prevent reconstitution response seropositive

项目摘要

ABSTRACT Human cytomegalovirus (HCMV) is the most common cause of congenital viral infection and an important cause of morbidity and mortality following solid organ and hematopoietic cell transplantation. Understanding how the immune system responds to HCMV is vital to the efforts to achieve efficient eradication of infection. This proposal aims to identify novel relationships between NK cells and T cells during HCMV infection, with the central hypothesis that a strong T cell response to HCMV infection can abrogate the emergence of an NK memory phenotype; reciprocally, a HCMV-activated NK cell can regulate the magnitude of the T-cell response. Using a unique fully autologous in vitro HCMV infection system, regulatory relationships between NK cells and T cells can be investigated and identified. Preliminary studies have generated the novel finding that direct interaction of NK cells with HCMV-infected dendritic cells induces PD-L1 surface expression on NK cells, which directly inhibits antibody-mediated T cell proliferation. To determine the impact of PDL1+ NK cell on HCMV antigen specific T cells, T cell responses to HCMV infection will be stimulated by the use of an artificial antigen-presenting cell pulsed with CMVpp65 peptides. Co-incubation of CMV-activated PDL1+ NK cells and CMV- sensitized T cells will permit elucidation of regulatory effects of one lymphocyte on the other. Additionally, preliminary data from an in vivo murine model has recapitulated findings in the human studies, showing a significant increase in the number of PDL1+ NK cells following MCMV infection of C57BL/6 mice. Using genetically novel murine systems, the in vivo impact of PDL1+ NK cells on MCMV-specific T cell responses and the efficiency of viral clearance will be determined. These murine models will allow for correlation of strength of the NK cell response with CMV-specific T cell responses and will also provide insight to how this relationship is controlled. The understanding of NK and T cell relationships developed in the in vitro and in vivo studies will be applied to the study of expansion and maintenance of adaptive NKG2C+ NK cells in healthy human donors as well as in patients with CMV reactivation following stem cell transplantation. The availability of blood samples from a cohort of hematopoietic cell transplant patients with CMV reactivation provides the unique opportunity to examine the NK and T cell repertoire in the setting of CMV infection. These studies will describe novel mechanisms that will expand existing knowledge on the balance of the adaptive and innate immune systems during viral infection and will provide further insight to mechanisms that can be targeted to prevent reactivation and chronic viral infection.

摘要